Latest Regulatory Approvals News

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.

Vintage Energy has signed a conditional agreement to acquire Metgasco's 25% interest in key Southern Flank gas joint ventures, aiming to accelerate production and value creation from the Vali and Odin fields.

Metgasco has agreed to sell its 25% stake in key Cooper Eromanga Basin gas fields to Vintage Energy for $5.9 million, marking a significant shift in its business focus. The deal hinges on Vintage securing funding and acquiring additional interests, with shareholder approval required.

Metgasco Ltd has entered a conditional agreement to sell its 25% stake in two gas fields in the Cooper Eromanga Basin to Vintage Energy for $5.9 million, marking a significant shift in its asset portfolio.

Clover Corporation Limited reported a standout FY25 with robust revenue growth and a sharp rise in profitability, underpinned by strategic market expansion and product innovation. The company’s strengthened balance sheet and optimistic FY26 outlook signal continued momentum.

Clover Corporation delivered a robust FY25 with strong second-half sales and operational milestones, positioning itself for continued growth in FY26 amid ongoing innovation and market expansion.

Tartana Minerals partners with Alt Resources in a $2 million joint venture to accelerate exploration of critical metals in Far North Queensland, focusing on tin, tungsten, and rare earth elements.

Elsight’s Halo platform has advanced to the final phase of a major U.S. Defense Innovation Unit challenge, securing significant funding and positioning the company at the forefront of a generational unmanned systems investment cycle.

Mayne Pharma updates investors on the extended FIRB approval deadline and potential financing hurdles in its proposed acquisition by Cosette Pharmaceuticals.

Emerald Resources has secured full development and operational permits for its Memot Gold Project in Cambodia, alongside an extension of the Okvau Gold Mine agreement to support underground mining. These approvals mark a pivotal step in the company’s expansion plans in Southeast Asia.

Excelsior Capital has settled its Federal Court dispute with London City Equities, paving the way for a capital return, fully franked dividend, and eventual delisting from the ASX.

Infomedia Ltd shareholders have overwhelmingly approved a scheme of arrangement for acquisition by TPG Capital, valuing the company at approximately AUD 651 million. The deal, supported by the board and an independent expert, is set to complete by early December 2025.